Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:person
|
| gptkbp:boardMemberOf |
gptkb:The_BMJ
|
| gptkbp:degree |
gptkb:PhD
|
| gptkbp:education |
gptkb:Johns_Hopkins_University
|
| gptkbp:employer |
gptkb:University_of_Maryland_School_of_Pharmacy
|
| gptkbp:field |
clinical trials
evidence-based medicine pharmaceutical health services research |
| gptkbp:hasORCID |
0000-0003-1613-9686
|
| https://www.w3.org/2000/01/rdf-schema#label |
Dr. Peter Doshi
|
| gptkbp:knownFor |
COVID-19 vaccine trial analysis
critique of pharmaceutical industry practices research on clinical trial transparency |
| gptkbp:nationality |
gptkb:American
|
| gptkbp:occupation |
associate professor
|
| gptkbp:bfsParent |
gptkb:Bent_Spoon_Award
|
| gptkbp:bfsLayer |
7
|